References
- Asam D, Spellerberg B. Molecular pathogenicity of Streptococcus anginosus. Mol Oral Microbiol. 2014 Aug;29(4):145–155. https://doi.org/10.1111/omi.12056
- Chen J, Domingue JC, Sears CL. Microbiota dysbiosis in select human cancers: Evidence of association and causality. Semin Immunol. 2017 Aug;32:25–34. https://doi.org/10.1016/j.smim.2017.08.001
- Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: A magic bullet? Science. 2013 Jan; 339(6117):286–291. https://doi.org/10.1126/science.1232227
- Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data.
- Dickson RP, Huffnagle GB. The lung microbiome: New principles for respiratory bacteriology in health and disease. PLoS Pathog. 2015 Jul;11(7): e1004923. https://doi.org/10.1371/journal.ppat.1004923
- Kassambara A, Kosinski M, Biecek P. survminer: Drawing Survival Curves using ‘ggplot2’. R package version: 0.4.9. Vienna (Austria): R Foundation for Statistical Computing; 2021. [cited 2023 Aug 7]. Available from https://CRAN.R-project.org/package=survminer
- Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieёrs G, Guery B, Delhaes L. The gut-lung axis in health and respiratory diseases: A place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol. 2020 Feb;10:9. https://doi.org/10.3389/fcimb.2020.00009
- Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Govindan R, Grannis FW Jr, et al. Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw. 2013 Jun;11(6):645–653. https://doi.org/10.6004/jnccn.2013.0084
- Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018 Jan;359(6371):97–103. https://doi.org/10.1126/science.aan4236
- Hashizume-Takizawa T, Yamaguchi Y, Kobayashi R, Shinozaki-Kuwahara N, Saito M, Kurita-Ochiai T. Oral challenge with Streptococcus sanguinis induces aortic inflammation and accelerates atherosclerosis in spontaneously hyperlipidemic mice. Biochem Biophys Res Commun. 2019 Dec;520(3):507–513. https://doi.org/10.1016/j.bbrc.2019.10.057
- Lê S, Josse J, Husson F. FactoMineR: An R package for multivariate analysis. J Stat Soft. 2008;25(1):1–18. https://doi.org/10.18637/jss.v025.i01
- Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, Zhou BS. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: A systematic review. Int J Cancer. 2009 Dec; 125(12):2936–2944. https://doi.org/10.1002/ijc.24636
- Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Thorac Oncol. 2013 Jul;8(7):823–859. https://doi.org/10.1097/JTO.0b013e318290868f
- Liu X, Cheng Y, Zang D, Zhang M, Li X, Liu D, Gao B, Zhou H, Sun J, Han X, et al. The role of gut microbiota in lung cancer: From carcinogenesis to immunotherapy. Front Oncol. 2021 Aug;11:720842. https://doi.org/10.3389/fonc.2021.720842
- Mao Q, Jiang F, Yin R, Wang J, Xia W, Dong G, Ma W, Yang Y, Xu L, Hu J. Interplay between the lung microbiome and lung cancer. Cancer Lett. 2018 Feb;415:40–48. https://doi.org/10.1016/j.canlet.2017.11.036
- de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol. 2012 Jun;13(6): 607–615. https://doi.org/10.1016/S1470-2045(12)70137-7
- Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, Luke JJ, Gajewski TF. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018 Jan;359(6371):104–108. https://doi.org/10.1126/science.aao3290
- Mazières J, Zalcman G, Crinò L, Biondani P, Barlesi F, Filleron T, Dingemans AM, Léna H, Monnet I, Rothschild SI, et al. Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort. J Clin Oncol. 2015 Mar;33(9):992–999. https://doi.org/10.1200/JCO.2014.58.3302
- Navratilova L, Bardon J, Novotny R, Zatloukal J, Jakubec P, Kolek V, Zapalka M, Kopriva F, Prochazkova P, Raclavsky V. The Streptococcus milleri group in chronic obstructive pulmonary disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Sep; 160(3):378–384. https://doi.org/10.5507/bp.2016.017
- Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020 May;368(6494):973–980. https://doi.org/10.1126/science.aay9189
- Oxnard GR, Binder A, Jänne PA. New targetable oncogenes in nonsmall-cell lung cancer. J Clin Oncol. 2013 Mar;31(8):1097–1104. https://doi.org/10.1200/JCO.2012.42.9829
- Parkins MD, Sibley CD, Surette MG, Rabin HR. The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: A case series and literature review. Pediatr Pulmonol. 2008 May; 43(5):490–497. https://doi.org/10.1002/ppul.20809
- R Core Team. R: A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2021 [cited 2023 Aug 7]. Available from https://www.R-project.org
- Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018 Jan;359(6371):91–97. https://doi.org/10.1126/science.aan3706
- Sędzikowska A, Szablewski L. Human gut microbiota in health and selected cancers. Int J Mol Sci. 2021 Dec;22(24):13440. https://doi.org/10.3390/ijms222413440
- Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB, et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2014 Nov; 371(21):1963–1971. https://doi.org/10.1056/NEJMoa1406766
- Song F, Qureshi AA, Gao X, Li T, Han J. Smoking and risk of skin cancer: A prospective analysis and a meta-analysis. Int J Epidemiol. 2012 Dec;41(6):1694–1705. https://doi.org/10.1093/ije/dys146
- Song Z, Zheng Y, Wang X, Su H, Zhang Y, Song Y. ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: A multicenter study of 732 cases. J Thorac Dis. 2017 Oct;9(10):3919–3926. https://doi.org/10.21037/jtd.2017.09.79
- Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012 Jun; 486(7402):207–214. https://doi.org/10.1038/nature11234
- Therneau T. A Package for Survival Analysis in R. R package version 3.5–7 [Internet]. Vienna (Austria): R Foundation for Statistical Computing; 2023 [cited 2023 Aug 7]. Available from https://CRAN.R-project.org/package=survival
- Tsai MS, Chen YY, Chen WC, Chen MF. Streptococcus mutans promotes tumor progression in oral squamous cell carcinoma. J Cancer. 2022 Sep;13(12):3358–3367. https://doi.org/10.7150/jca.73310
- Tsay JJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, Li Y, Yie TA, Lhakhang T, Olsen E, et al. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am J Respir Crit Care Med. 2018 Nov;198(9):1188–1198. https://doi.org/10.1164/rccm.201710-2118OC
- Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: Microbiome in cancer. Protein Cell. 2021 May;12(5):426–435. https://doi.org/10.1007/s13238-020-00813-8
- Yang JJ, Yu D, Xiang YB, Blot W, White E, Robien K, Sinha R, Park Y, Takata Y, Lazovich D, et al. Association of dietary fiber and yogurt consumption with lung cancer risk: A pooled analysis. JAMA Oncol. 2020 Feb;6(2):e194107. https://doi.org/10.1001/jamaoncol.2019.4107
- Yue T, Li J, Zhu J, Zuo S, Wang X, Liu Y, Liu J, Liu X, Wang P, Chen S. Hydrogen sulfide creates a favorable immune microenvironment for colon cancer. Cancer Res. 2023 Feb;83(4):595–612. https://doi.org/10.1158/0008-5472.CAN-22-1837
- Zhang WL, Wang SS, Wang HF, Tang YJ, Tang YL, Liang XH. Who is who in oral cancer? Exp Cell Res. 2019 Nov;384(2):111634. https://doi.org/10.1016/j.yexcr.2019.111634
- Zhou CB, Pan SY, Jin P, Deng JW, Xue JH, Ma XY, Xie YH, Cao H, Liu Q, Xie WF, et al. Fecal signatures of Streptococcus anginosus and Streptococcus constellatus for noninvasive screening and early warning of gastric cancer. Gastroenterology. 2022 Jun;162(7):1933–1947.e18. https://doi.org/10.1053/j.gastro.2022.02.015